| |
|
|
|
Citius Pharmaceuticals Inc.  
|
|
1.0664 -0.014 (-0.01%) |
08-23 15:49 |
|
Open: |
1.08 |
Pre close: |
1.08 |
Target:
|
1.54
|
|
High: |
1.0936 |
Low: |
1.06 |
Resistance:
|
1.32
1.50
|
|
Volume: |
18,158 |
Market Cap: |
24M |
Support:
|
1.03
0.86
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.08
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
1.15 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
1.12 |
Stochastic Oscillator |
%K(14,3):
|
13.16  |
|
MA(250): |
1.24 |
%D(3): |
12.39 |
|
Average Volume(K) |
3-Month: |
8780
|
52-Week |
High:
|
2.52 |
|
10-Days: |
2873 |
Low: |
0.86 |
|
RSI |
RSI(14):
|
44.84 |
Change(%): |
-19.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.821 |
Return on Equity (ttm) |
-68.4 |
Shares Out. (M) |
9.98 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-39.5 |
Shares Float (M) |
7.87 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
43.10 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
4.20 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
154 |
|
Book Value (p.s.) |
0.970 |
EBITDA (p.s.) |
-1.563 |
P/E |
-1.30 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.10 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.04 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-6.78 |
P/CF |
-0.88 |
|
|
|
|
|
|
